chemical, biological or immunological components, solutions or preparations intended by the manufacturer to be used as an IVD medical device

equipment or apparatus intended by a manufacturer to be used as an IVD medical device

device, whether used alone or in combination, intended by the manufacturer for the in vitro examination of specimens derived from the human body solely or principally to provide information for diagnostic, monitoring or compatibility purposes and including reagents, calibrators, control materials, specimen receptacles, software, and related instruments or apparatus or other articles

chemical, biological or immunological components, solutions or preparations intended by the manufacturer to be used as an IVD medical device

any circumstance that contributes to or causes the degradation (3.1.17) of a building (ISO 6707-1:2014, 3.1.3)(3.1.10)/ constructed assets (3.1.15) or a part of it under normal use

any circumstance that can impact on the performance (3.1.78.1)(3.1.78.2) of a building (ISO 6707-1:2014, 3.1.3)(3.1.10) or a constructed asset (3.1.15), or a part thereof, under normal use

any circumstance that can impact the performance (3.1.78.1)(3.1.78.2) of a building (ISO 6707-1:2014, 3.1.3)(3.1.10) or a constructed asset (3.1.15), or a part thereof under normal use

tariff for surplus energy exported to the grid, applied by an energy supplier to someone who installs an electricity generating technology from a renewable or low energy carbon source

how a whole building (ISO 6707-1:2014, 3.1.3)(3.1.10), structure (ISO 6707-1:2014, 3.1.4) or unit of construction works (ISO 6707-1:2014, 3.1.1), or a system or component (3.1.13) or part thereof actually functions in its intended place and use

qualitative level of a critical property (ISO 6707-1:2014, 9.1.3) at any point in time considered